Fluoroquinolones suppress gluconeogenesis by inhibiting fructose 1,6-bisphosphatase in primary monkey hepatocytes.

Published on Jan 29, 2020in Toxicology in Vitro2.959
· DOI :10.1016/J.TIV.2020.104786
Takuma Iguchi5
Estimated H-index: 5
(Daiichi Sankyo),
Koichi Goto1
Estimated H-index: 1
(Daiichi Sankyo)
+ 5 AuthorsKazuhiko Mori9
Estimated H-index: 9
(Daiichi Sankyo)
Source
Abstract
Abstract Dysglycemia is one of the most serious adverse events associated with the clinical use of certain fluoroquinolones. The purpose of this study was to investigate the effects of the representative fluoroquinolones moxifloxacin and gatifloxacin on hepatic gluconeogenesis using primary monkey hepatocytes. Glucose production was induced after the cells were incubated for 4 h with 10 mM sodium lactate and 1 mM sodium pyruvate as gluconeogenic substrates. Under these conditions, moxifloxacin and gatifloxacin dose-dependently suppressed gluconeogenesis at concentrations of 100 μM or higher. Transcriptome analysis of rate-limiting enzymes involved in hepatic gluconeogenesis revealed that moxifloxacin and gatifloxacin at a concentration of 1000 μM did not affect the expression of key gluconeogenic enzymes such as phosphoenolpyruvate carboxykinase, glucose 6-phosphatase, and fructose 1,6-bisphosphatase. Furthermore, metabolome analysis, in vitro glucose production assay using additional gluconeogenic substrates, and fructose 1,6-bisphosphatase assay using the cell extracts showed that fluoroquinolones enzymatically suppressed hepatic gluconeogenesis by inhibiting fructose 1,6-bisphosphatase. These inhibitory effects may involve in the clinically relevant dysglycemia associated with fluoroquinolones in human.
📖 Papers frequently viewed together
3 Citations
91 Citations
22 Citations
References36
Newest
#1Xueping Zhang (Sichuan University)H-Index: 2
#2Shanshan Yang (Sichuan University)H-Index: 2
Last. Zhiguang Su (Sichuan University)H-Index: 18
view all 4 authors...
Hepatic gluconeogenesis, de novo glucose synthesis from available precursors, plays a crucial role in maintaining glucose homeostasis to meet energy demands during the prolonged starvation in animals. The abnormally increased rate of hepatic gluconeogenesis contributes to the hyperglycemia of diabetes. Gluconeogenesis is regulated on multiple levels, such as hormonal secretion, gene transcription and posttranslational modification. We review here the molecular mechanisms underlying the transcrip...
49 CitationsSource
#1Koichi Yabe (Daiichi Sankyo)H-Index: 6
#2Yuka Yamamoto (Daiichi Sankyo)H-Index: 35
Last. Kazuhiko Mori (Daiichi Sankyo)H-Index: 9
view all 5 authors...
We characterized pancreatic islet lesions induced by several quinolones using functional and morphological examinations of the pancreatic islets in male rats orally administered gatifloxacin, lomef...
1 CitationsSource
#1Yu Yoshimatsu (Daiichi Sankyo)H-Index: 3
#2Tomomichi Ishizaka (Daiichi Sankyo)H-Index: 4
Last. Kazuhiko Mori (Daiichi Sankyo)H-Index: 9
view all 4 authors...
Drug-induced cardiac electrophysiological abnormalities accompanied by hypoglycemia or hyperglycemia increase the risk for life-threatening arrhythmia. To assess the drug-induced cardiotoxic potential associated with extraordinary blood glucose (GLU) levels, the effect of gatifloxacin (GFLX) which was frequently associated with GLU abnormality and QT/QTc prolongations in the clinic on blood GLU and electrocardiogram (ECG) parameters was investigated in cynomolgus monkeys (n=4) given GFLX orally ...
4 CitationsSource
#1Stephanie T. Chung (NIH: National Institutes of Health)H-Index: 19
#2Shaji Chacko (BCM: Baylor College of Medicine)H-Index: 15
Last. Morey W. Haymond (BCM: Baylor College of Medicine)H-Index: 84
view all 4 authors...
Gluconeogenesis is a complex metabolic process that involves multiple enzymatic steps regulated by myriad factors, including substrate concentrations, the redox state, activation and inhibition of specific enzyme steps, and hormonal modulation. At present, the most widely accepted technique to determine gluconeogenesis is by measuring the incorporation of deuterium from the body water pool into newly formed glucose. However, several techniques using radioactive and stable-labeled isotopes have b...
35 CitationsSource
#1Liangyou Rui (UM: University of Michigan)H-Index: 40
The liver is an essential metabolic organ, and its metabolic function is controlled by insulin and other metabolic hormones. Glucose is converted into pyruvate through glycolysis in the cytoplasm, and pyruvate is subsequently oxidized in the mitochondria to generate ATP through the TCA cycle and oxidative phosphorylation. In the fed state, glycolytic products are used to synthesize fatty acids through de novo lipogenesis. Long-chain fatty acids are incorporated into triacylglycerol, phospholipid...
804 CitationsSource
#1Mais Absi (University of Manchester)H-Index: 5
#2Hussam Ghareeb (University of Aleppo)H-Index: 1
Last. Urs T. Ruegg (University of Geneva)H-Index: 51
view all 4 authors...
Fluoroquinolone antibiotics cause rare, but clinically important, adverse events including hyperglycaemia and hypoglycaemia. The present study focuses on the possible effect of levofloxacin and moxifloxacin on the cardiovascular functions of rats with type I diabetes. Both antibiotics caused bradycardia. Levofloxacin but not moxifloxacin caused hypoglycaemia in diabetic rats and an increase in amplitude of the ST segment revealed by electrocardiogram (ECG) analysis of isolated hearts. In pressur...
3 CitationsSource
#1Zheng Chen (UM: University of Michigan)H-Index: 18
#2Liang Sheng (UM: University of Michigan)H-Index: 11
Last. Liangyou RuiH-Index: 7
view all 7 authors...
Obesity is associated with intrahepatic inflammation that promotes insulin resistance and type 2 diabetes. Tumor necrosis factor receptor–associated factor (TRAF)2 is a key adaptor molecule that is known to mediate proinflammatory cytokine signaling in immune cells; however, its metabolic function remains unclear. We examined the role of hepatic TRAF2 in the regulation of insulin sensitivity and glucose metabolism. TRAF2 was deleted specifically in hepatocytes using the Cre/loxP system. The muta...
38 CitationsSource
#1Azusa Uchida (Tokyo Medical and Dental University)H-Index: 1
#2Hiroki Sasaguri (Tokyo Medical and Dental University)H-Index: 7
Last. Takanori Yokota (Tokyo Medical and Dental University)H-Index: 43
view all 26 authors...
Amyotrophic lateral sclerosis is a fatal neurodegenerative disease characterized by progressive motoneuron loss. Redistribution of transactive response deoxyribonucleic acid-binding protein 43 from the nucleus to the cytoplasm and the presence of cystatin C-positive Bunina bodies are considered pathological hallmarks of amyotrophic lateral sclerosis, but their significance has not been fully elucidated. Since all reported rodent transgenic models using wild-type transactive response deoxyribonuc...
74 CitationsSource
#1Christopher J. Ramnanan (Vandy: Vanderbilt University)H-Index: 21
#2Dale S. Edgerton (Vandy: Vanderbilt University)H-Index: 25
Last. Alan D. Cherrington (Vandy: Vanderbilt University)H-Index: 83
view all 11 authors...
OBJECTIVE Insulin-mediated suppression of hepatic glucose production (HGP) is associated with sensitive intracellular signaling and molecular inhibition of gluconeogenic (GNG) enzyme mRNA expression. We determined, for the first time, the time course and relevance (to metabolic flux) of these molecular events during physiological hyperinsulinemia in vivo in a large animal model. RESEARCH DESIGN AND METHODS 24 h fasted dogs were infused with somatostatin, while insulin (basal or 8× basal) and glu...
73 CitationsSource
#1Mikiko Nagai (Iwate University)H-Index: 1
#2Saori Nagata (Iwate University)H-Index: 2
Last. Kazuhisa Furuhama (Iwate University)H-Index: 16
view all 5 authors...
To ascertain the clinicopathological process underlying dysglycemia induced by the fluoroquinolone antibacterial gatifloxacin (GFLX), we orally administered 100 or 300 mg/kg/day to male clinically healthy (naive) or spontaneous type II (diabetic) Goto-Kakizaki rats for 15 days (days 1 to 15). Treatment of naive rats with GFLX led to decreased blood glucose concentrations at 100 mg/kg/day on day 1. In diabetic animals, markedly increased blood glucose concentrations were noted from 100 mg/kg/day ...
5 CitationsSource
Cited By1
Newest
Source